(142 days)
No
The device description and performance studies focus on the mechanical function and biocompatibility of a needle for injection, with no mention of AI or ML capabilities.
No
The device is described as an injection needle intended for delivering substances into the uterine and bladder walls, which is a delivery mechanism, not a therapeutic action itself.
No
The device is described as an injection needle intended for therapeutic purposes (injecting substances into the uterine or bladder wall), not for diagnosing conditions or diseases.
No
The device description explicitly states it consists of a handle, shaft, and injection needle, which are physical hardware components.
Based on the provided information, the LiNA OperaScope™ Needle is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use is for direct injection into the uterine and urinary bladder walls. This is a therapeutic or procedural use, not a diagnostic test performed on samples taken from the body.
- Device Description: The device is a needle designed for injection, not for analyzing biological samples.
- Lack of IVD Characteristics: There is no mention of the device being used to examine or analyze biological specimens (like blood, urine, tissue samples) outside of the body to provide diagnostic information.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide information about a person's health status, such as diagnosing diseases, monitoring treatments, or screening for conditions. The LiNA OperaScope™ Needle's function is to deliver substances directly into tissue, which is a procedural action, not a diagnostic test.
N/A
Intended Use / Indications for Use
LiNA OperaScope™ Needle is intended for hysteroscopic injection into the uterine wall as well as for cystoscopic injection in the urinary bladder wall.
Product codes
FBK, HIH
Device Description
LiNA OperaScope™ Needle is delivered as a sterile, single-use device designed to be used specifically with the LiNA OperaScope for hysteroscopic and cystoscopic injections. The device consists of a handle, a shaft and an injection needle, which is pointed at the distal end and has a luer-lock connection at the proximal end. Devices are packed in Tyvek pouches, with 6 units packed in a box.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
uterine wall, urinary bladder wall
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Trained Medical Professionals – Gynecologists and Urologists / Hospital and Physician Offices
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Functional bench testing was performed to demonstrate the adequate functionality of the LiNA OperaScope Needle, including:
- Insertion in Tissue: , ISO 10993-11:2017
- Hemocompatibility: ASTM F756-17
Shelf-life testing: The LiNA OperaScope Needle has a shelf life of 3 years when packaged in Tyvek pouches, in accordance with the results of accelerated aged stability studies. Results demonstrated that the devices could maintain their specifications over the stated shelf-life duration.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.1500 Endoscope and accessories.
(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, with the letters "FDA" in a blue square. Next to that is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
September 2, 2022
LiNA Medical ApS % Scott Blood Director of Regulatory Services MEDIcept, Inc. 200 Homer Avenue Ashland, MA 01821
Re: K221085
Trade/Device Name: LiNA OperaScope™ Needle Regulation Number: 21 CFR§ 876.1500 Regulation Name: Endoscope and Accessories Regulatory Class: II Product Code: FBK, HIH Dated: July 29, 2022 Received: August 4, 2022
Dear Scott Blood:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
1
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Jason R. Roberts, Ph.D. Assistant Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K221085
Device Name LiNA OperaScope™ Needle
Indications for Use (Describe)
LiNA OperaScope™ Needle is intended for hysteroscopic injection into the uterine wall as for cystoscopic injection in the urinary bladder wall.
| Type of Use (Select one or both, as applicable) |
|---|
| Transactional Use (Limited to SEC Rule 144A and/or Regulation S) |
| Other - Direct placement with accredited investors |
X | Prescription Use (Part 21 CFR 801 Subpart D)
| | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary LiNA OperaScope™ Needle K221085
1. Submission Sponsor
LiNA Medical ApS Formervangen 5 DK-2600 Glostrup, Denmark Contact: Jarosław Mrówczyński Title: Regulatory Affairs Manager Email: jmr@lina-medical.com Office number: +48 61 222 21 21
2. Submission Correspondent
Scott Blood Director of Regulatory Services MEDIcept Inc. 200 Homer Ave Ashland, MA 01721 Email: SBlood@medicept.com Office number: +1 978-729-5978
3. Date Prepared
September 1, 2022
4. Device Identification
| Trade/Proprietary Name: | LiNA OperaScope™ Needle |
|---|---|
| Common/Usual Name: | Needle |
| Classification Name: | Endoscope and Accessories |
| Regulation Number: | 876.1500 |
| Primary Product Code: | FBK |
| Reference Product Code: | HIH |
| Device Class: | Class II |
| Classification Panel: | Gastroenterology/Urology |
5. Legally Marketed Predicate Device(s)
Through FDA database search following predicate device has been identified: Cook Injection Needles manufactured by Cook Urological, Inc (K022484). No design-related recalls for these legally marketed predicate devices have been identified.
4
6. Indication for Use Statement
LiNA OperaScope™ Needle is intended for hysteroscopic injection into the uterine wall as well as for cystoscopic injection in the urinary bladder wall.
7. Device Description
LiNA OperaScope™ Needle is delivered as a sterile, single-use device designed to be used specifically with the LiNA OperaScope for hysteroscopic and cystoscopic injections. The device consists of a handle, a shaft and an injection needle, which is pointed at the distal end and has a luer-lock connection at the proximal end. Devices are packed in Tyvek pouches, with 6 units packed in a box. Model numbers are presented in Table 1.
| Reference number | Description |
|---|---|
| OP-NEE4-6 | LiNA OperaScope™ Needle 4mm, minimum channel |
| diameter: Ø2.0mm | |
| OP-NEE8-6 | LiNA OperaScope™ Needle 8mm, minimum channel |
| diameter: Ø2.0mm |
8. Substantial Equivalence Discussion
Cook Injection Needle (K022484)
The LiNA OperaScope Needle is similar to the Cook Injection Needle in terms of indications for use and technological characteristics (required inner channel diameter, needle length, tip shape and presence of Luer lock).
Table 2 compares the LiNA OperaScope Needle to the predicate device with respect to the indications for use, principles of operation, materials, dimensions and operational mode. The predicate specifies needles are only intended to be used with rigid endoscopes.
5
| Manufacturer | LiNA Medical ApS | Cook Urological | |
|---|---|---|---|
| Trade Name | LiNA OperaScope™ Needle | ||
| (K221085) | Cook Injection Needles | ||
| (K022484) | |||
| Common Name | Endoscopic Injection Needle, Gastroenterology-urology; | Endoscopic Injection Needle, Gastroenterology-urology | |
| Primary Product | |||
| Code | FBK | FBK | |
| Regulation | |||
| Number | 876.1500 | 876.1500 | |
| Regulation Name | Endoscope and Accessories; | Endoscope and Accessories | |
| Indications for | |||
| Use | LiNA OperaScope™ Needle is intended for hysteroscopic injection into the | ||
| uterine wall as well as for cystoscopic injection in the urinary bladder | |||
| wall. | The Cook Injection Needles are used to deliver a variety of injectable | ||
| materials into tissues during laparoscopic, hysteroscopic, cystoscopic, | |||
| endoscopic transurethral procedures and open surgical procedures. The | |||
| type of material to be injected will be dependent on the nature of the | |||
| procedure. The needle is intended to be used with legally marketed drugs | |||
| and devices. | |||
| Intended Users | Trained Medical Professionals – Gynecologists and Urologists | Trained Medical Professionals - Gynecologists and Urologists | |
| Site of Use | Hospital and Physician Offices | Hospital and Physician Offices | |
| Route of | |||
| advancement | Advanced to the bladder via the urethra and to the uterus via the cervix | ||
| through the working channel of the endoscope. | Advanced to the bladder via the urethra and to the uterus via the cervix | ||
| through the working channel of the endoscope. | |||
| Required channel | |||
| inner diameter | 5 Fr | 3.7 to 9 Fr | |
| Needle length | 4 or 8 mm | Unknown | |
| Needle width | 23G | 16-25G | |
| Working length | 313 mm | 150 - 650 mm | |
| Tip shape | 3-bevel tip | 3-bevel tip | |
| Sterilization | |||
| method | EtO | EtO | |
| Duration of use | ≤ 24 hours | ≤ 24 hours | |
| Frequency of use | Single use | Single use | |
| Components | Injection Needle with Luer lock fitting to the syringe and protection cap | ||
| for the tip | Injection Needle with Luer lock fit to the syringe | ||
| Patient | |||
| Contacting | |||
| Materials | The LiNA OperaScope Needle is tested according to ISO 10993 to assure | ||
| that patient contacting materials are biocompatible. | Compliant with ISO 10993 |
| Table 2 - Comparison LiNA OperaScope Needle and predicate device | ||||
|---|---|---|---|---|
| -- | -- | -- | -- | ------------------------------------------------------------------ |
6
| Manufacturer | LiNA Medical ApS | Cook Urological |
|---|---|---|
| Trade Name | LiNA OperaScope™ Needle | |
| (K221085) | Cook Injection Needles | |
| (K022484) | ||
| Packaging | Tyvek pouch for single device, | |
| 6 devices packed in box | Tyvek-Poly Pouch | |
| Shelf Life | 36 months | 36 months |
LiNA OperaScope™ Needle is designed specifically for LiNA OperaScope and adjusted to the technical requirements of this device.
The LiNA OperaScope Needle has the similar indications for use and technological characteristics as compared to the differences in indications for use do not constitute a new intended use. Additionally, there are no different questions of safety and effectiveness that arise from the differences in technological differences between LiNA OperaScope Needle and the predicate device can be evaluated through performance testing and do not alter the intended use of the LiNA OperaScope Needle.
7
9. Non-Clinical Performance Data
In an effort to demonstrate safety and effectiveness of the LiNA OperaScope Needle and to support equivalence to the predicate devices that are subject to this 510(k) submission, LiNA completed a number of non-clinical performance tests. The LiNA OperaScope Needle met all the requirements for overall design, sterilization and biocompatibility results confirming that the design output meets the design inputs and specifications for the device.
Functional Testing:
Functional bench testing was performed to demonstrate the adequate functionality of the LiNA OperaScope Needle, as follows:
- Insertion in Tissue , ISO 10993-11:2017
- Hemocompatibility: ASTM F756-17 ●
8
Shelf-Life:
The LiNA OperaScope Needle has a shelf life of 3 years when packaged in Tyvek pouches, in accordance with the results of accelerated aged stability studies. Results from testing demonstrated that the devices could maintain their specifications over the stated shelf-life duration.
10. Clinical Performance Data
Not applicable for LiNA OperaScope Needle.
11. Statement of Substantial Equivalence
The LiNA OperaScope™ Needle has the same intended use as the predicate device. The LiNA OperaScope™ Needle has different technological characteristics from the predicate device, but these differences do not raise different questions of safety and effectiveness. Performance testing, as described above, demonstrates that the LiNA OperaScope™ Needle is as safe and effective as the predicate. Therefore, the LiNA OperaScope™ Needle is substantially equivalent to the referenced predicate device.